Use App
  • Trending
  • News
  • Earnings
DIADIA0.08%
SPYSPY0.07%
QQQQQQ1.35%
Trending
Top trending tickerMETAMETA8.67%
MUMU11.55%
JACKJACK10.12%
CEGCEG4.76%
DRAM13.15%
TDOCTDOC7.31%
RIOTRIOT12.34%
KORUKORU27.43%
ONDOONDO4.92%
SOUNSOUN4.33%
Top trending tickerMETAMETA8.67%
MUMU11.55%
JACKJACK10.12%
CEGCEG4.76%
DRAM13.15%
TDOCTDOC7.31%
RIOTRIOT12.34%
KORUKORU27.43%
ONDOONDO4.92%
SOUNSOUN4.33%

Feed

News

Sentiment

Earnings

Fundamentals

Info

homeSymbolVTGN
Exchange: NASDAQ·Updated 07:58 PM EDT
VTGN logo

VTGNVistaGen Therapeutics Inc

$0.243
$0.017
(7.52%)
Today
·Closed $0.243
$0.0006
(0.25%)
After Hours
This Stock Lost 71% Of Value After Anxiety Therapy Missed Key Goals – But Retail Believes It’s Oversold, Says Won’t Panic-SellNews·This Stock Lost 71% Of Value After Anxiety Therapy Missed Key Goals – But Retail Believes It’s Oversold, Says Won’t Panic-Sell
Reported EarningsJun 15
Mkt Cap$9.27M
Vol14.58M

Fundamentals

Mkt Cap
$9.27M
Volume
-
52W High
$5.14
52W Low
$0.198
PE Ratio
-0.13
Avg. Volume
3.21M
EPS (Annual)
-$1.83
P/B
0.27
Rev/Employee
$30,951.22
Earnings
Jun 15

Advertisement|Remove ads.

Latest VTGN News

View
This Stock Lost 71% Of Value After Anxiety Therapy Missed Key Goals – But Retail Believes It’s Oversold, Says Won’t Panic-Sell
Stocktwits
News Placeholder
Vistagen Announces Topline and Post-Hoc Data from PALISADE-4 Phase 3 Public Speaking Challenge Trial of Fasedienol for the Acute Treatment of Social Anxiety Disorder
Business Wire
News Placeholder
Vistagen Reports Fiscal Year 2026 Financial Results and Provides Corporate Update
Business Wire
News Placeholder
Loading...
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.

TrendingNews
CommunityProfile